Recent studies suggest that betaKlotho (KLB) and endocrine FGF19 and FGF21 redirect FGFR signaling to regulation of metabolic homeostasis and suppression of obesity and diabetes. Here, FGF19 is linked to obesity due to melanocortin 4 receptor deficiency.